tacrine has been researched along with Alloxan Diabetes in 1 studies
Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, Q | 1 |
| Matsumoto, K | 1 |
| Tsuneyama, K | 1 |
| Tanaka, K | 1 |
| Li, F | 1 |
| Shibahara, N | 1 |
| Miyata, T | 1 |
| Yokozawa, T | 1 |
1 other study available for tacrine and Alloxan Diabetes
| Article | Year |
|---|---|
Diabetes-induced central cholinergic neuronal loss and cognitive deficit are attenuated by tacrine and a Chinese herbal prescription, kangen-karyu: elucidation in type 2 diabetes db/db mice.
Topics: Animals; Brain; Cholinergic Neurons; Cognition Disorders; Diabetes Mellitus, Experimental; Diabetes | 2011 |